Myxosarcoma is a rare type of cancer that starts in connective tissue. It often looks like a benign tumor but can become cancerous. It's usually found in the muscles or fat tissue.
Every report comes from a Lived member, sent anonymously.
Have you had Surgery for Myxosarcoma?
Myxosarcoma is a cancer of the body's soft connective tissue (a sarcoma) in which much of the tumor is made of myxoid tissue: a soft, gel-like material rich in mucus-like substances that resembles very early, undeveloped connective tissue. It most often shows up as a painless lump that grows slowly, usually in an arm or a leg. Pain or other symptoms tend to appear only when the tumor becomes large enough to press on nearby nerves, muscles or organs. Myxosarcoma is an older, descriptive name rather than a single disease. Today, pathologists usually give a more specific diagnosis, and the two most common are myxofibrosarcoma, a sarcoma of fibrous tissue that mostly affects people in their 60s to 80s, and myxoid liposarcoma, a sarcoma of fat-forming cells that most often grows deep in the thigh. The specific type matters because the types grow, spread and respond to treatment differently. Myxosarcoma is also different from a myxoma, which is a benign (noncancerous) tumor of similar-looking tissue.
In most people, no cause is ever found. The known risk factors are those for soft tissue sarcomas in general: some inherited conditions, such as Li-Fraumeni syndrome and neurofibromatosis type 1; earlier radiation therapy to the area; long-lasting lymphedema (swelling of an arm or leg from poor lymph drainage); and exposure to certain chemicals, such as vinyl chloride or arsenic. These raise the chance of a sarcoma, but most people who develop one have none of them. Myxoid liposarcoma carries a characteristic gene change inside the tumor cells, in which two genes have broken and joined together (a gene fusion). It is a feature of the tumor that helps confirm the diagnosis, not something a person did. Some people first notice a lump after a knock or injury, which can make it look like a bruise or a collection of blood at first and delay the diagnosis.
Assessment usually starts with an examination and an ultrasound scan of the lump. MRI (magnetic resonance imaging) is the preferred scan for showing the tumor's size, its edges and how it relates to nearby muscles, nerves and blood vessels. Myxofibrosarcoma often sends thin strands of tumor along the layers of tissue around it, and MRI helps surgeons see that spread before they plan an operation. Only a biopsy can confirm a sarcoma. This is usually a core needle biopsy, in which several small samples are taken through a wide needle, often guided by imaging. Ideally it is planned with the team who will do the surgery, and the samples are examined by a pathologist experienced in sarcomas, since these tumors are rare and easily confused with other growths. Special stains and genetic tests on the tissue identify the exact type, for example by finding the gene fusion of myxoid liposarcoma. The pathologist also gives the tumor a grade (low, intermediate or high), based on how abnormal the cells look and how quickly they are dividing. High-grade tumors usually grow and spread faster. Together with the tumor's size and whether it has spread, the grade sets the stage. Staging scans usually include a CT (computed tomography) scan of the chest, because the lungs are the most common place for sarcomas to spread. For myxoid liposarcoma, which tends to spread to other soft tissues and bones, especially the spine, doctors increasingly use a whole-body MRI as well.
Surgery is the main treatment. The aim is to remove the tumor in one piece with a margin (a surrounding layer) of healthy tissue, often about 1 to 2 centimeters for myxofibrosarcoma, to lower the chance of it coming back. Most operations on an arm or leg keep the limb, and amputation is rarely needed. Large tumors may leave a gap that is closed with a muscle flap or skin graft. Outcomes are better when the first operation is planned by an experienced sarcoma team. When a lump is removed without imaging and a biopsy first, because no one suspected a sarcoma, the chance of the tumor returning is higher, and a second operation is often needed. Radiation therapy, given before or after surgery, is often added for larger or higher-grade tumors to reduce the chance of the tumor coming back in the same place. Myxoid liposarcoma responds to radiation unusually well, so radiation before surgery is commonly used to shrink it first. For myxofibrosarcoma, radiation is widely used, but studies disagree about how much it helps. A small, low-grade tumor may need surgery alone. Chemotherapy is considered when a tumor is large and high-risk, when it cannot be removed or when it has spread. Myxoid liposarcoma is more responsive to chemotherapy than many sarcomas. Trabectedin (Yondelis) is an intravenous cancer drug approved for adults with liposarcoma that cannot be removed or has spread, after earlier treatment with anthracycline chemotherapy. For myxofibrosarcoma, the value of chemotherapy after surgery is still uncertain. Because these cancers are rare, care at a specialized sarcoma center, where surgeons, radiation and medical oncologists and pathologists plan treatment together, and clinical trials of newer treatments such as immunotherapy are worth asking about.
The outlook depends mostly on the exact type, the grade, the size and whether the whole tumor was removed with clear margins. Low-grade myxofibrosarcoma rarely spreads elsewhere, but it often comes back in the same area, because its strands of tumor can extend beyond what is visible. Intermediate- and high-grade myxofibrosarcoma spreads in roughly one in six to two in five people, most often to the lungs. Myxoid liposarcoma usually responds well to combined radiation and surgery, but it can spread to soft tissues or bones, sometimes several years after treatment. Recovery after surgery and radiation varies with the size and site of the tumor. A large operation on a limb may involve reconstruction and time to recover strength and movement. After treatment, follow-up continues for years, with regular examinations and scans of the original site and the chest, plus other imaging for myxoid liposarcoma. These visits aim to find a recurrence while it is still small enough to treat, often with more surgery or radiation.
Have a doctor examine any lump in the soft tissues that you cannot explain, and arrange an ultrasound scan without delay if the lump is getting bigger. A swelling after an injury that has not gone away after a few weeks also deserves a scan rather than more waiting. If a lump is going to be removed, ask beforehand whether imaging and a biopsy are needed first. After treatment, contact your sarcoma team soon, rather than waiting for the next scheduled visit, if you notice a new lump in or near the treated area or a new symptom that does not settle, such as persistent pain or cough.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Myxosarcoma is like, what's helped you, or ask the community a question.